New data presented at CHEST 2024 in Boston revealed a significant link between obstructive sleep apnea and mental health disorders in middle-aged and older adults.
New data presented at CHEST 2024 in Boston revealed a significant link between obstructive sleep apnea (OSA) and mental health disorders in middle-aged and older adults. Lead investigator Tetyana Kendzerska, MD, associate professor, Division of Respirology, University of Ottawa, and clinical director, Sleep Center, Ottaway Hospital, discussed the large-scale secondary analysis of data from the Canadian Longitudinal Study on Aging (CLSA).
The study evaluated data from 30,097 participants, aged 45 to 85 years, to assess whether self-reported OSA was associated with an increased risk of mental health–related symptoms and diagnoses.
“Importantly, we consistently found a relationship between risk of sleep apnea and mental health conditions,” Kendzerska explained in an interview. “And cross-sectionally and longitudinally, we found a 30% to 60% increase in odds of having mental health conditions in people at high risk for sleep apnea, and we have done multiple sensitivity analyses. We have tried multiple definitions for sleep apnea, we tried multiple definitions for mental health just to test the robustness of our findings, and we confirmed this finding in different analyses.”
Key findings indicate that 25.9% of participants were at high risk for OSA, and those individuals had a notably higher prevalence of mental health issues compared with those without OSA. Specifically, 52.9% of those with OSA risk reported a composite mental health disorder, compared with 41.0% without OSA risk. Additionally, rates of anxiety disorders, mood disorders, clinical depression, psychological distress, and depressive symptoms were all higher among those at high risk for OSA.
The study highlights the need for further research to confirm this association, adjust for potential confounding factors, and explore the long-term effects of OSA on mental health. These findings could help guide the development of screening programs and interventions targeting individuals with concurrent OSA and mental health conditions.
Reference
Kendzerska T, Mallick R, Li W, et al. The relationship between concurrent mental health disorders and sleep-disordered breathing: a secondary cross-sectional analysis of the Canadian Longitudinal Study on Aging. CHEST. 2024;166(4):A6194-A6195.
STEER Data Open Door to SMA Gene Therapy for Wider Age Range of Children
March 19th 2025Delivery of onasemnogene abeparvovec into the intrathecal space was safe and effective for children with spinal muscular atrophy (SMA) aged 2 to 17 years, who had previously been shut out of receiving gene therapy.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
EMBARK Data Show Continued Improvements With DMD Gene Therapy
March 19th 2025Data from the EMBARK trial of delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD) show that benefits in functional outcomes, gene expression, and muscle imaging persist 2 years after receiving the gene therapy.
Read More
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More